AllianceBernstein
BBNX

AllianceBernstein’s Beta Bionics BBNX Stock Holding History

AllianceBernstein’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Hold
35,400
– – ﹤0.01% 2312
2025
Q4 		$1.08M Buy
35,400
+10,900
+44% +$291K ﹤0.01% 2309
2025
Q3 		$487K Sell
24,500
-168,825
-87% -$2.97M ﹤0.01% 2697
2025
Q2 		$2.81M Sell
193,325
-903,938
-82% -$12.8M ﹤0.01% 1764
2025
Q1 		$13.4M Buy
+1,097,263
New +$20.5M ﹤0.01% 1024

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein's BBNX Position: Q1 2026 in Review

AllianceBernstein held its Beta Bionics (BBNX) position steady in Q1 2026 at 35,400 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

AllianceBernstein first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.4M in Q1 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • AllianceBernstein held 35,400 shares of Beta Bionics worth $1.08M as of Q1 2026.
  • AllianceBernstein left its Beta Bionics share count unchanged in Q1 2026.
  • Beta Bionics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2312 holding.
  • AllianceBernstein first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • AllianceBernstein's Beta Bionics position peaked at $13.4M in Q1 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.